The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of oral 5-azacitidine in combination with romidepsin in advanced solid tumors with an expansion cohort in virally mediated cancers and liposarcoma.
 
Kim Anna Reiss
Employment - Champions Oncology (I)
Research Funding - Champions Oncology (I)
 
Michelle A. Rudek
Employment - Amplimmune (I); Novavax (I)
Stock and Other Ownership Interests - Amplimmune (I); Novavax (I)
Research Funding - Celgene
 
Susan Sartorius-Mergenthaler
No Relationships to Disclose
 
Melinda Downs
No Relationships to Disclose
 
David Cosgrove
No Relationships to Disclose
 
Stephanie Gaillard
No Relationships to Disclose
 
Stephen Baylin
No Relationships to Disclose
 
Nita Ahuja
Consulting or Advisory Role - Celgene
 
Nilofer Saba Azad
Honoraria - Merck
Research Funding - Astex Pharmaceuticals; Celgene; Genentech; GlaxoSmithKline; Kinex; Precision Therapeutics
Travel, Accommodations, Expenses - Merck